Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma

Archive ouverte

Böhm, Steffen | Montfort, Anne | Pearce, Oliver | Topping, Joanne | Chakravarty, Probir | Everitt, Gemma | Clear, Andrew | Mcdermott, Jackie | Ennis, Darren | Dowe, Thomas | Fitzpatrick, Amanda | Brockbank, Elly | Lawrence, Alexandra | Jeyarajah, Arjun | Faruqi, Asma | Mcneish, Iain | Singh, Naveena | Lockley, Michelle | Balkwill, Frances

Edité par CCSD ; American Association for Cancer Research -

International audience. Abstract Purpose: The purpose of this study was to assess the effect of neoadjuvant chemotherapy (NACT) on immune activation in stage IIIC/IV tubo-ovarian high-grade serous carcinoma (HGSC), and its relationship to treatment response. Experimental Design: We obtained pre- and posttreatment omental biopsies and blood samples from a total of 54 patients undergoing platinum-based NACT and 6 patients undergoing primary debulking surgery. We measured T-cell density and phenotype, immune activation, and markers of cancer-related inflammation using IHC, flow cytometry, electrochemiluminescence assays, and RNA sequencing and related our findings to the histopathologic treatment response. Results: There was evidence of T-cell activation in omental biopsies after NACT: CD4+ T cells showed enhanced IFNγ production and antitumor Th1 gene signatures were increased. T-cell activation was more pronounced with good response to NACT. The CD8+ T-cell and CD45RO+ memory cell density in the tumor microenvironment was unchanged after NACT but biopsies showing a good therapeutic response had significantly fewer FoxP3+ T regulatory (Treg) cells. This finding was supported by a reduction in a Treg cell gene signature in post- versus pre-NACT samples that was more pronounced in good responders. Plasma levels of proinflammatory cytokines decreased in all patients after NACT. However, a high proportion of T cells in biopsies expressed immune checkpoint molecules PD-1 and CTLA4, and PD-L1 levels were significantly increased after NACT. Conclusions: NACT may enhance host immune response but this effect is tempered by high/increased levels of PD-1, CTLA4, and PD-L1. Sequential chemoimmunotherapy may improve disease control in advanced HGSC. Clin Cancer Res; 22(12); 3025–36. ©2016 AACR.

Consulter en ligne

Suggestions

Du même auteur

A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases

Archive ouverte | Montfort, Anne | CCSD

International audience. Purpose: In high-grade serous ovarian cancer (HGSOC), higher densities of both B cells and the CD8+ T-cell infiltrate were associated with a better prognosis. However, the precise role of B c...

Abstract 455: B cells actively participate to the anti-cancer immune response in high grade serous ovarian cancer metastases

Archive ouverte | Montfort, Anne | CCSD

International audience. Abstract Intra-tumor B cells and immunoglobulin signatures have been associated with a better clinical prognosis in ovarian cancer (Iglesia et al, 2014; Nielsen et al, 2012). However little i...

The genomic trajectory of ovarian high‐grade serous carcinoma can be observed in STIC lesions

Archive ouverte | Cheng, Zhao | CCSD

International audience. Abstract Ovarian high‐grade serous carcinoma (HGSC) originates in the fallopian tube, with secretory cells carrying a TP53 mutation, known as p53 signatures, identified as potential precursor...

Chargement des enrichissements...